Solo RNS20 Aug 2018 12:08
The conditions precedent to the Sale and Purchase Agreement ("SPA") have now been fulfilled and the Company will now receive £650,000 in cash and 9,973,011 ordinary Solo shares of 0.2p in fulfilment of the share consideration based on the 10-day Solo volume weighted average price as provided for in the SPA. It is expected that the Solo shares will be admitted to trading on or around the 15 March and under the terms of the SPA, Primorus will not trade in Solo shares for a period of at least 45 days from completion